Mott D A, Collins T M
College of Pharmacy, Ohio State University, Columbus 43210, USA.
J Am Pharm Assoc (Wash). 1998 May-Jun;38(3):325-32. doi: 10.1016/s1086-5802(16)30328-x.
To examine the impact on dipyridamole prescribing of a letter mailed to pharmacists and/or physicians.
Interrupted time series with control series.
State of Wisconsin.
Physicians and pharmacists caring for patients who were prescribed dipyridamole.
The state of Wisconsin was divided into four sections, three of which were designated as experimental regions (letter to physician only, letter to pharmacist only, and letter to both physician and pharmacist) and one of which served as a control region.
Cost of drug per patient per month in ambulatory and long-term care populations.
For 763 long-term care and 586 ambulatory Medicaid patients, letters sent to both physicians and pharmacists resulted in significant reductions in dipyridamole expenditures relative to the control group. For long-term care patients, interventions directed at both physicians and pharmacists produced significant reductions in dipyridamole prescribing relative to interventions directed at physicians alone or pharmacists alone.
Future DUR letter interventions designed to change prescribing habits would be more effective if they targeted both physicians and pharmacists, particularly in the long-term care setting.
研究寄给药剂师和/或医生的一封信对双嘧达莫处方开具的影响。
带有对照系列的中断时间序列。
威斯康星州。
为开具双嘧达莫处方的患者提供护理的医生和药剂师。
威斯康星州被分为四个区域，其中三个被指定为实验区域（仅给医生的信、仅给药剂师的信以及给医生和药剂师的信），另一个作为对照区域。
门诊和长期护理人群中每位患者每月的药品费用。
对于763名长期护理和586名门诊医疗补助患者，与对照组相比，同时发给医生和药剂师的信件使双嘧达莫支出显著减少。对于长期护理患者，针对医生和药剂师的干预措施相对于仅针对医生或仅针对药剂师的干预措施，在双嘧达莫处方开具方面产生了显著减少。
如果未来旨在改变处方习惯的药物利用评价（DUR）信件干预措施同时针对医生和药剂师，尤其是在长期护理环境中，将会更有效。
